Breast Cancer Clinical Trials

9082 clinical trials for Breast Cancer across international registries, including 1275 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer — RECRUITING · PHASE2
• Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer — RECRUITING · PHASE2
• Exercise Oncology Clinic Pilot Feasibility Trial — RECRUITING · NA
• A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer — RECRUITING · NA
• An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors — RECRUITING · PHASE1
• Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT) — RECRUITING · NA
• Natural History Study of Early Life Exposures in Agriculture (ELEA) — RECRUITING
• Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia — RECRUITING · NA
• Harvesting Cells for Experimental Cancer Treatments — RECRUITING
• Weight Management After Cancer for Survivors in Rural Communities — RECRUITING · NA
• Genomic Services Research Program — RECRUITING
• Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers — RECRUITING · PHASE1
• Collection of Blood From Patients With Cancer — RECRUITING
• Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial — RECRUITING · NA
• FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer — RECRUITING · PHASE1
• The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER — RECRUITING · PHASE3
• Diagnostic Prediction Model for De Novo Metastatic Breast Cancer — RECRUITING
• Behavioral Pain Intervention for Older Cancer Patients — RECRUITING · NA
• Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial — RECRUITING · PHASE3
• Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI) — RECRUITING · NA
• A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies — RECRUITING · PHASE1
• Copenhagen Master Observational Trial — RECRUITING
• Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC — RECRUITING · PHASE2
• 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors — RECRUITING · NA
• PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan — RECRUITING
• Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer — RECRUITING · PHASE2
• Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging — RECRUITING · NA
• A Study of MGC026 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer — RECRUITING · PHASE2
• A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative Cancer — RECRUITING · PHASE1
• Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer — RECRUITING · NA
• Supporting Health Including Endocrine Treatment for Long Duration — RECRUITING · NA
• Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics — RECRUITING · NA
• Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer — RECRUITING
• A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE2
• A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer — RECRUITING · PHASE1
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) — RECRUITING · PHASE1
• IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases — RECRUITING · PHASE2
• Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia — RECRUITING
• BEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy — RECRUITING
• Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue — RECRUITING
• A Prospective Multicenter Study of the TuFEst-LN Model for Axillary Lymph Node Status Assessment in Breast Cancer — RECRUITING
• A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors — RECRUITING · PHASE1
• Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies — RECRUITING
• Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer — RECRUITING · PHASE2
• Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery — RECRUITING · NA
• Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC — RECRUITING · PHASE3
• DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs — RECRUITING · PHASE2
• Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast — RECRUITING · PHASE2
• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — RECRUITING · PHASE3

Refine this search